The abstract is read at the publisher; the summary is JClub's.
In paired tumor–blood TCRβ profiling of 13 endometrial cancer patients, blood detectability rises 2.44-fold per tenfold increase in intratumoral tumor frequency, and shared clonotypes are enriched in tumors.
- Why it matters: Endometrial cancer immune heterogeneity is not fully captured by genomic and histopathological descriptors, leaving uncertainty about how adaptive T-cell repertoires relate across compartments.
- What they did: The study profiled TCRβ repertoires from paired tumor biopsies and peripheral-blood mononuclear cells in 13 molecularly characterized patients, defining clonotypes by exact CDR3 amino-acid identity and using matched-depth resampling (500) to assess sharing.
- The result: Tumor biopsies contained fewer clonotypes than matched blood in 13/13 patients, and higher tumor mutational burden was linked to lower intratumoral Hill D1 (Spearman ρ=-0.833; BH q=0.0115), supporting quantitative tumor–blood repertoire architecture for immunogenomic stratification.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.